251
|
Cullmann M, Hilding A, Östenson CG. Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population. Diabet Med 2012; 29:441-52. [PMID: 21916972 DOI: 10.1111/j.1464-5491.2011.03450.x] [Citation(s) in RCA: 92] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
AIMS Alcohol is a potential risk factor of Type 2 diabetes. However, more detailed information on effects of alcohol types and early phases of Type 2 diabetes development seems warranted. The aim of this study was to investigate the influence of alcohol consumption and specific alcoholic beverages on the risk of developing pre-diabetes and Type 2 diabetes in middle-aged Swedish men and women. METHODS Subjects, who at baseline had normal glucose tolerance (2070 men and 3058 women) or pre-diabetes (70 men and 41 women), aged 35-56 years, were evaluated in this cohort study. Logistic regression was performed to estimate the risk [odds ratio (OR) and 95% confidence interval (CI)] to develop pre-diabetes and Type 2 diabetes at 8-10 years follow-up, in relation to self-reported alcohol intake at baseline. Adjustment was performed for several risk factors. RESULTS Total alcohol consumption and binge drinking increased the risk of pre-diabetes and Type 2 diabetes in men (OR 1.42, 95% CI 1.00-2.03 and OR 1.67, 95% CI 1.11-2.50, respectively), while low consumption decreased diabetes risk in women (OR 0.41, 95% CI 0.22-0.79). Men showed higher risk of pre-diabetes with high beer consumption (OR 1.84, 95% CI 1.13-3.01) and of Type 2 diabetes with high consumption of spirits (OR 2.03, 95% CI 1.27-3.24). Women showed a reduced risk of pre-diabetes with high wine intake (OR 0.66, 95% CI 0.43-0.99) and of Type 2 diabetes with medium intake of both wine and spirits (OR 0.46, 95% CI 0.24-0.88 and OR 0.55, 95% CI 0.31-0.97, respectively), whereas high consumption of spirits increased the pre-diabetes risk(OR 2.41, 95% CI 1.47-3.96). CONCLUSION High alcohol consumption increases the risk of abnormal glucose regulation in men. In women the associations are more complex: decreased risk with low or medium intake and increased risk with high alcohol intake.
Collapse
Affiliation(s)
- M Cullmann
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
| | | | | |
Collapse
|
252
|
Romelsjö A, Allebeck P, Andréasson S, Leifman A. Alcohol, Mortality and Cardiovascular Events in a 35 Year Follow-up of a Nationwide Representative Cohort of 50,000 Swedish Conscripts up to Age 55. Alcohol Alcohol 2012; 47:322-7. [DOI: 10.1093/alcalc/ags021] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
|
253
|
Park SH. Association between alcohol consumption and metabolic syndrome among Korean adults: nondrinker versus lifetime abstainer as a reference group. Subst Use Misuse 2012; 47:442-9. [PMID: 22233521 DOI: 10.3109/10826084.2011.648043] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
BACKGROUND Discrepant results regarding the association between alcohol consumption and metabolic syndrome may be partly attributable to the different selection of the reference group. METHODS Data from a representative sample of 6,432 Korean adults in 2008 were analyzed. RESULTS Using lifetime abstainers as the reference group, the prevalence of metabolic syndrome among men was increased in ex-drinkers [3.15 (1.69-5.89)], responsible drinking [0.1-39.9 g/day; 1.77 (1.0-3.13)], and hazardous drinking [≥40 g/day; 2.06 (1.05-4.07)]. CONCLUSIONS Alcohol consumption in men, but not in women, is associated with a higher prevalence of metabolic syndrome.
Collapse
Affiliation(s)
- Seung Ha Park
- Department of Internal Medicine, Inje University Haeundae Paik-Hospital, Inje University College of Medicine, Busan, Republic of Korea.
| |
Collapse
|
254
|
Abstract
There has been a growing consensus that moderate consumption of alcohol is associated with a lower risk of mortality and that this association is probably causal. However, a recent review article has raised a serious challenge to this consensus. In short, it determined that most prior research in this area committed serious misclassification errors; furthermore, among those studies that were free of these misclassification errors, no support for a protective role of alcohol consumption was found. This article reexamines the issue using prospective data for more than 124,000 persons interviewed in the U.S. National Health Interview Surveys of 1997 through 2000 with mortality follow-up through 2002 using the Linked Mortality File. The study involves about 488,000 person-years. Controlling for a variety of covariates, this study finds that compared with nondrinkers, those who consume a moderate amount of alcohol have lower all-cause and CHD mortality. The fact that the current study has taken care to avoid the pitfalls of some earlier studies and still finds that those who consume a moderate amount of alcohol have lower all-cause mortality and CHD mortality lends credence to the argument that the relationship is causal.
Collapse
|
255
|
Movva R, Figueredo VM. Alcohol and the heart: to abstain or not to abstain? Int J Cardiol 2012; 164:267-76. [PMID: 22336255 DOI: 10.1016/j.ijcard.2012.01.030] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/07/2011] [Revised: 01/07/2012] [Accepted: 01/19/2012] [Indexed: 12/12/2022]
Abstract
Alcohol has been consumed by most societies over the last 7000 years. Abraham Lincoln said "It has long been recognized that the problems with alcohol relate not to the use of a bad thing, but to the abuse of a good thing." Light to moderate alcohol consumption reduces the incidence of coronary heart disease (CHD), ischemic stroke, peripheral arterial disease, CHD mortality, and all-cause mortality, especially in the western populations. However, heavy alcohol consumption is detrimental causing cardiomyopathy, cardiac arrhythmias, hepatic cirrhosis, pancreatitis, and hemorrhagic stroke. In this article, we review the effects of alcohol on CHD, individual cardiovascular risk factors, cardiomyopathy, and cardiac arrhythmias, including the most recent evidence of the effects of alcohol on CHD.
Collapse
Affiliation(s)
- Rajesh Movva
- Albert Einstein Medical Center, Philadelphia, PA 19141, United States
| | | |
Collapse
|
256
|
Kim KH, Oh SW, Kwon H, Park JH, Choi H, Cho B. Alcohol consumption and its relation to visceral and subcutaneous adipose tissues in healthy male Koreans. ANNALS OF NUTRITION AND METABOLISM 2012; 60:52-61. [PMID: 22327000 DOI: 10.1159/000334710] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/24/2011] [Accepted: 10/22/2011] [Indexed: 12/19/2022]
Abstract
AIMS The purpose of the present study is to investigate the association of alcohol with visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) distribution and metabolic syndrome (MetS). DESIGN We conducted a cross-sectional study in 951 healthy male Korean participants who underwent health checkups. We measured the cross-sectional areas of VAT and SAT by computed tomography of the abdomen and performed a study of alcohol consumption based on questionnaire responses and a 24-hour dietary recall assessment. We analyzed the relationship of alcohol consumption with VAT, SAT, and MetS. RESULTS Alcohol consumption showed a negative association with SAT (β = -18.76, p = 0.047) but a positive association with VAT (β = 17.70, p = 0.037), independent of other factors. The adjusted odds ratios for MetS for those who consumed <7, 7 to <14, 14 to <28, and ≥28 standard drinks per week were 0.99 (0.59-1.68), 1.49 (0.84-2.63), 1.95 (1.10-3.45), and 1.99 (1.07-3.70), respectively (p for linear trend = 0.042). CONCLUSIONS Alcohol consumption is associated with decreased SAT and increased VAT accumulation. Further, alcohol consumption of ≥14 standard drinks is associated with an increased risk of MetS. Light-to-moderate drinking, which has been regarded to lower the risk of cardiovascular diseases, did not show a protective effect on adipose tissue accumulation.
Collapse
Affiliation(s)
- Kyae Hyung Kim
- Department of Family Medicine, Seoul National University Hospital, Seoul, Korea
| | | | | | | | | | | |
Collapse
|
257
|
Abstract
Studies have suggested that moderate alcohol consumption is associated with a reduced risk of CVD and premature mortality in individuals with diabetes mellitus. However, history of alcohol consumption has hardly been taken into account. We investigated the association between current alcohol consumption and mortality in men and women with diabetes mellitus accounting for past alcohol consumption. Within the European Prospective Investigation into Cancer and Nutrition (EPIC), a cohort was defined of 4797 participants with a confirmed diagnosis of diabetes mellitus. Men and women were assigned to categories of baseline and past alcohol consumption. Hazard ratios (HR) and 95 % CI for total mortality were estimated with multivariable Cox regression models, using light alcohol consumption (>0-6 g/d) as the reference category. Compared with light alcohol consumption, no relationship was observed between consumption of 6 g/d or more and total mortality. HR for >6-12 g/d was 0·89 (95 % CI 0·61, 1·30) in men and 0·86 (95 % CI 0·46, 1·60) in women. Adjustment for past alcohol consumption did not change the estimates substantially. In individuals who at baseline reported abstaining from alcohol, mortality rates were increased relative to light consumers: HR was 1·52 (95 % CI 0·99, 2·35) in men and 1·81 (95 % CI 1·04, 3·17) in women. The present study in diabetic individuals showed no association between current alcohol consumption >6 g/d and mortality risk compared with light consumption. The increased mortality risk among non-consumers appeared to be affected by their past alcohol consumption rather than their current abstinence.
Collapse
|
258
|
Magnus P, Bakke E, Hoff DA, Høiseth G, Graff-Iversen S, Peggy Knudsen G, Myhre R, Trygve Normann P, Næss Ø, Tambs K, Thelle DS, Mørland J. Controlling for High-Density Lipoprotein Cholesterol Does Not Affect the Magnitude of the Relationship Between Alcohol and Coronary Heart Disease. Circulation 2011; 124:2296-302. [DOI: 10.1161/circulationaha.111.036491] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background—
This study tested the hypothesis that moderate alcohol intake exerts its cardioprotective effect mainly through an increase in the serum level of high-density lipoprotein cholesterol.
Methods and Results—
In the Cohort of Norway (CONOR) study, 149 729 adult participants, recruited from 1994 to 2003, were followed by linkage to the Cause of Death Registry until 2006. At recruitment, questionnaire data on alcohol intake were collected, and the concentration of high-density lipoprotein cholesterol in serum was measured. Using Cox regression, we found that the adjusted hazard ratio for men for dying from coronary heart disease was 0.52 (95% confidence interval, 0.39–0.69) when consuming alcohol more than once a week compared with never or rarely. The ratio changed only slightly, to 0.55 (0.41–0.73), after the regression model included the serum level of high-density cholesterol. For women, the corresponding hazard ratios were 0.62 (0.32–1.23) and 0.68 (0.34–1.34), respectively.
Conclusions—
Alcohol intake is related to a reduced risk of death from coronary heart disease in the follow-up of a large, population-based Norwegian cohort study with extensive control for confounding factors. Our findings suggest that the serum level of high-density cholesterol is not an important intermediate variable in the possible causal pathway between moderate alcohol intake and coronary heart disease.
Collapse
Affiliation(s)
- Per Magnus
- From the Divisions of Epidemiology (P.M., D.A.H., S.G.-I., R.M., Ø.N., D.S.T.), Forensic Medicine and Drug Abuse Research (E.B., G.H., P.T.N., J.M.), and Mental Health (G.P.K., K.T.), Norwegian Institute of Public Health, Oslo; and Faculty of Medicine, University of Oslo (P.M., D.S.T., J.M.), Norway
| | - Eirin Bakke
- From the Divisions of Epidemiology (P.M., D.A.H., S.G.-I., R.M., Ø.N., D.S.T.), Forensic Medicine and Drug Abuse Research (E.B., G.H., P.T.N., J.M.), and Mental Health (G.P.K., K.T.), Norwegian Institute of Public Health, Oslo; and Faculty of Medicine, University of Oslo (P.M., D.S.T., J.M.), Norway
| | - Dominic A. Hoff
- From the Divisions of Epidemiology (P.M., D.A.H., S.G.-I., R.M., Ø.N., D.S.T.), Forensic Medicine and Drug Abuse Research (E.B., G.H., P.T.N., J.M.), and Mental Health (G.P.K., K.T.), Norwegian Institute of Public Health, Oslo; and Faculty of Medicine, University of Oslo (P.M., D.S.T., J.M.), Norway
| | - Gudrun Høiseth
- From the Divisions of Epidemiology (P.M., D.A.H., S.G.-I., R.M., Ø.N., D.S.T.), Forensic Medicine and Drug Abuse Research (E.B., G.H., P.T.N., J.M.), and Mental Health (G.P.K., K.T.), Norwegian Institute of Public Health, Oslo; and Faculty of Medicine, University of Oslo (P.M., D.S.T., J.M.), Norway
| | - Sidsel Graff-Iversen
- From the Divisions of Epidemiology (P.M., D.A.H., S.G.-I., R.M., Ø.N., D.S.T.), Forensic Medicine and Drug Abuse Research (E.B., G.H., P.T.N., J.M.), and Mental Health (G.P.K., K.T.), Norwegian Institute of Public Health, Oslo; and Faculty of Medicine, University of Oslo (P.M., D.S.T., J.M.), Norway
| | - Gun Peggy Knudsen
- From the Divisions of Epidemiology (P.M., D.A.H., S.G.-I., R.M., Ø.N., D.S.T.), Forensic Medicine and Drug Abuse Research (E.B., G.H., P.T.N., J.M.), and Mental Health (G.P.K., K.T.), Norwegian Institute of Public Health, Oslo; and Faculty of Medicine, University of Oslo (P.M., D.S.T., J.M.), Norway
| | - Ronny Myhre
- From the Divisions of Epidemiology (P.M., D.A.H., S.G.-I., R.M., Ø.N., D.S.T.), Forensic Medicine and Drug Abuse Research (E.B., G.H., P.T.N., J.M.), and Mental Health (G.P.K., K.T.), Norwegian Institute of Public Health, Oslo; and Faculty of Medicine, University of Oslo (P.M., D.S.T., J.M.), Norway
| | - Per Trygve Normann
- From the Divisions of Epidemiology (P.M., D.A.H., S.G.-I., R.M., Ø.N., D.S.T.), Forensic Medicine and Drug Abuse Research (E.B., G.H., P.T.N., J.M.), and Mental Health (G.P.K., K.T.), Norwegian Institute of Public Health, Oslo; and Faculty of Medicine, University of Oslo (P.M., D.S.T., J.M.), Norway
| | - Øyvind Næss
- From the Divisions of Epidemiology (P.M., D.A.H., S.G.-I., R.M., Ø.N., D.S.T.), Forensic Medicine and Drug Abuse Research (E.B., G.H., P.T.N., J.M.), and Mental Health (G.P.K., K.T.), Norwegian Institute of Public Health, Oslo; and Faculty of Medicine, University of Oslo (P.M., D.S.T., J.M.), Norway
| | - Kristian Tambs
- From the Divisions of Epidemiology (P.M., D.A.H., S.G.-I., R.M., Ø.N., D.S.T.), Forensic Medicine and Drug Abuse Research (E.B., G.H., P.T.N., J.M.), and Mental Health (G.P.K., K.T.), Norwegian Institute of Public Health, Oslo; and Faculty of Medicine, University of Oslo (P.M., D.S.T., J.M.), Norway
| | - Dag S. Thelle
- From the Divisions of Epidemiology (P.M., D.A.H., S.G.-I., R.M., Ø.N., D.S.T.), Forensic Medicine and Drug Abuse Research (E.B., G.H., P.T.N., J.M.), and Mental Health (G.P.K., K.T.), Norwegian Institute of Public Health, Oslo; and Faculty of Medicine, University of Oslo (P.M., D.S.T., J.M.), Norway
| | - Jørg Mørland
- From the Divisions of Epidemiology (P.M., D.A.H., S.G.-I., R.M., Ø.N., D.S.T.), Forensic Medicine and Drug Abuse Research (E.B., G.H., P.T.N., J.M.), and Mental Health (G.P.K., K.T.), Norwegian Institute of Public Health, Oslo; and Faculty of Medicine, University of Oslo (P.M., D.S.T., J.M.), Norway
| |
Collapse
|
259
|
Kerr WC, Greenfield TK, Bond J, Ye Y, Rehm J. Racial and ethnic differences in all-cause mortality risk according to alcohol consumption patterns in the national alcohol surveys. Am J Epidemiol 2011; 174:769-78. [PMID: 21856649 PMCID: PMC3203376 DOI: 10.1093/aje/kwr147] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2010] [Accepted: 04/10/2011] [Indexed: 11/12/2022] Open
Abstract
Previous studies have found J-shaped relations between volume of alcohol consumed and mortality risk in white Americans but not in African Americans, suggesting the need for studies in which race/ethnicity-defined subgroups are analyzed in separate comparable models. In the present study, the authors utilized mortality follow-up data (through 2006) on respondents from the 1984 and 1995 National Alcohol Surveys, including similar numbers of black, white, and Hispanic respondents by oversampling the minority groups. Cox proportional hazards models controlling for demographic, socioeconomic, mental health, and drug- and tobacco-use measures were used to estimate mortality risk from all causes. Findings indicated a protective effect of moderate alcohol drinking (2-30 drinks/month for women and 2-60 drinks/month for men) with no monthly ≥5-drink days) relative to lifetime abstention for whites only. Elevated mortality risk relative to moderate drinking was found in former drinkers with lifetime alcohol problems. Moderate drinkers who consumed ≥5 drinks in 1 day at least monthly were also found to have increased risk, suggesting the importance of identifying heavy-occasion drinking for mortality analyses. These differential results regarding lifetime abstainers may suggest bias from differential unmeasured confounding or unmeasured aspects of alcohol consumption pattern or may be due to genetic differences in the health impact of alcohol metabolism.
Collapse
Affiliation(s)
- William C Kerr
- Alcohol Research Group, Public Health Institute, Emeryville, California, USA.
| | | | | | | | | |
Collapse
|
260
|
Roerecke M, Greenfield TK, Kerr WC, Bondy S, Cohen J, Rehm J. Heavy drinking occasions in relation to ischaemic heart disease mortality-- an 11-22 year follow-up of the 1984 and 1995 US National Alcohol Surveys. Int J Epidemiol 2011; 40:1401-10. [PMID: 22039198 DOI: 10.1093/ije/dyr129] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
BACKGROUND The relationship between alcohol consumption and ischaemic heart disease (IHD) risk is complex and several issues remain unresolved because many studies used rather crude exposure measures often based on one or two questions. The objective of this study was to investigate the association between heavy drinking occasions and IHD mortality while controlling for average daily alcohol intake and separating former drinkers from lifetime abstainers. METHODS Cox regression analyses were used with IHD mortality as the outcome in a sample of 9934 participants of the US National Alcohol Surveys conducted in 1984 and 1995. RESULTS To the end of 2006, 326 deaths from IHD were recorded in the 11- to 22-year follow-up period. Any past heavy drinking occasions in former drinkers [hazard ratio (HR) = 2.06; 95% confidence interval (95% CI): 1.10-3.85] compared with former drinkers without such drinking occasions, and any heavy drinking occasion in current drinkers at baseline (HR = 2.05; 95% CI: 1.03-3.98) compared with current drinkers with average daily intake of one to two drinks, were associated with higher IHD mortality in men and any heavy drinking occasions among drinkers of up to 1 drink average consumption in women with similar effect size. Confounding effects from age, race, education, employment, income, marital status, geographical region, depression score, survey period or other drug use were small. CONCLUSIONS Among former and current drinkers, heavy drinking occasions should be taken into account when examining the complex association of alcohol consumption on IHD mortality risk.
Collapse
|
261
|
Alcohol Consumption, New Onset of Diabetes After Transplantation, and All-Cause Mortality in Renal Transplant Recipients. Transplantation 2011; 92:203-9. [DOI: 10.1097/tp.0b013e318222ca10] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
262
|
Eapen DJ, Manocha P, Valiani K, Mantini N, Sperling L, McGorisk GM. Alcohol and the heart: an ounce of prevention. CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE 2011; 13:313-25. [PMID: 21562797 DOI: 10.1007/s11936-011-0131-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
OPINION STATEMENT Moderate alcohol intake is beneficial to the heart and cardiovascular system. A J- or U-shaped response has been shown in the majority of studies examining alcohol's effect on cardiovascular mortality and downstream cardio-metabolic effects, with heavy alcohol intake associated with worse outcomes. These effects apply to individuals with and without underlying coronary artery disease. However, care must be taken in defining "moderate" intake between the sexes. Males appear to have a wider therapeutic window and can afford 2 to 3 drinks per day whereas women should limit intake to 1 to 2 drinks per day (a "drink" being classified as 10 to 14 grams of alcohol). More than half of alcohol's cardioprotective effects can be attributed to its effect on lipoproteins, specifically an increase in high-density lipoprotein. Interestingly, the risk of cardiovascular mortality in former heavy drinkers has been shown to ultimately approach the risk seen in lifelong abstainers.
Collapse
Affiliation(s)
- Danny J Eapen
- Department of Medicine, Division of Cardiology, Emory University School of Medicine, 1364 Clifton Rd, D 407-B, Atlanta, GA, 30322, USA,
| | | | | | | | | | | |
Collapse
|
263
|
Abstract
ABSTRACTThis review was undertaken for the Faculty and Institute of Actuaries as part of their programme to encourage research collaborations between health researchers and actuaries in order to understand better the factors influencing mortality and longevity. The authors presented their findings in a number of linked sessions at the Edinburgh conference (Joining Forces on Mortality and Longevity) in October 2009 and contributed to this overview. The purpose is to review evidence for the impact on adult mortality of characteristics of the individual's lifetime socioeconomic or psychosocial environment or phenotype at the behavioural; multi-system (e.g. cognitive and physical function); or body system level (e.g. vascular and metabolic traits) that may be common risk factors for a number of major causes of death. This review shows there is growing evidence from large studies and systematic reviews that these individual characteristics, measured in pre-adult as well as the adult life, are associated with later mortality risk. The relative contribution of lifetime environment, genetic factors and chance, whether these contributions change with age, and the underlying social and biological pathways are still to be clarified. This review identifies areas where further life course research is warranted.
Collapse
|
264
|
Lue HH, Chen CH, Chang WH. Dimension reduction in survival regressions with censored data via an imputed spline approach. Biom J 2011; 53:426-43. [PMID: 21495063 DOI: 10.1002/bimj.201000168] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2010] [Revised: 01/20/2011] [Accepted: 02/01/2011] [Indexed: 11/07/2022]
Abstract
Dimension reduction methods have been proposed for regression analysis with predictors of high dimension, but have not received much attention on the problems with censored data. In this article, we present an iterative imputed spline approach based on principal Hessian directions (PHD) for censored survival data in order to reduce the dimension of predictors without requiring a prespecified parametric model. Our proposal is to replace the right-censored survival time with its conditional expectation for adjusting the censoring effect by using the Kaplan-Meier estimator and an adaptive polynomial spline regression in the residual imputation. A sparse estimation strategy is incorporated in our approach to enhance the interpretation of variable selection. This approach can be implemented in not only PHD, but also other methods developed for estimating the central mean subspace. Simulation studies with right-censored data are conducted for the imputed spline approach to PHD (IS-PHD) in comparison with two methods of sliced inverse regression, minimum average variance estimation, and naive PHD in ignorance of censoring. The results demonstrate that the proposed IS-PHD method is particularly useful for survival time responses approximating symmetric or bending structures. Illustrative applications to two real data sets are also presented.
Collapse
Affiliation(s)
- Heng-Hui Lue
- Department of Statistics, Tunghai University, Taichung, Taiwan.
| | | | | |
Collapse
|
265
|
Judd SE, McClure LA, Howard VJ, Lackland DT, Halanych JH, Kabagambe EK. Heavy drinking is associated with poor blood pressure control in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2011; 8:1601-12. [PMID: 21655140 PMCID: PMC3108130 DOI: 10.3390/ijerph8051601] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/10/2011] [Revised: 04/29/2011] [Accepted: 05/05/2011] [Indexed: 11/17/2022]
Abstract
Alcohol intake has been shown to have a J-shaped association with blood pressure (BP). However, this association has not been examined in mixed race populations or in people with diabetes where tighter blood pressure control is recommended. Participants in the REGARDS study who were 45 years or older (n = 30,239) were included. Medical history (including self-reported alcohol intake) was collected by telephone while blood collection and clinical measurements were done during an in-home visit. We defined diabetes as use of medications and/or fasting glucose ≥ 126 mg/dL and hypertension as use of blood pressure lowering medications and/or BP ≥ 140/90 mmHg or BP ≥ 130/80 mmHg in people with diabetes. After adjustment for confounders, heavy drinking was associated with an increased odds of hypertension (OR = 1.59; 95% CI = 1.37, 1.87). Diabetes and gender significantly modified (interaction P < 0.05 for both) the association between alcohol use and hypertension, although heavy drinking remained associated with increased odds of hypertension in sub-group analyses. We did not observe the previously described J-shaped relationship in any sub-group except white females. These data suggest heavy alcohol consumption is associated with poor BP control and that heavy drinkers may want to consider limiting alcohol intake in order to manage hypertension.
Collapse
Affiliation(s)
- Suzanne E. Judd
- Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL 35294, USA; E-Mail: (L.A.M.)
| | - Leslie A. McClure
- Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL 35294, USA; E-Mail: (L.A.M.)
| | - Virginia J. Howard
- Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL 35294, USA; E-Mails: (V.J.H.); (E.K.K.)
| | - Daniel T. Lackland
- Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA; E-Mail:
| | - Jewell H. Halanych
- Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA; E-Mail:
| | - Edmond K. Kabagambe
- Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL 35294, USA; E-Mails: (V.J.H.); (E.K.K.)
| |
Collapse
|
266
|
|
267
|
Schumann G, Coin LJ, Lourdusamy A, Charoen P, Berger KH, Stacey D, Desrivières S, Aliev FA, Khan AA, Amin N, Aulchenko YS, Bakalkin G, Bakker SJ, Balkau B, Beulens JW, Bilbao A, de Boer RA, Beury D, Bots ML, Breetvelt EJ, Cauchi S, Cavalcanti-Proença C, Chambers JC, Clarke TK, Dahmen N, de Geus EJ, Dick D, Ducci F, Easton A, Edenberg HJ, Esko T, Fernández-Medarde A, Foroud T, Freimer NB, Girault JA, Grobbee DE, Guarrera S, Gudbjartsson DF, Hartikainen AL, Heath AC, Hesselbrock V, Hofman A, Hottenga JJ, Isohanni MK, Kaprio J, Khaw KT, Kuehnel B, Laitinen J, Lobbens S, Luan J, Mangino M, Maroteaux M, Matullo G, McCarthy MI, Mueller C, Navis G, Numans ME, Núñez A, Nyholt DR, Onland-Moret CN, Oostra BA, O'Reilly PF, Palkovits M, Penninx BW, Polidoro S, Pouta A, Prokopenko I, Ricceri F, Santos E, Smit JH, Soranzo N, Song K, Sovio U, Stumvoll M, Surakk I, Thorgeirsson TE, Thorsteinsdottir U, Troakes C, Tyrfingsson T, Tönjes A, Uiterwaal CS, Uitterlinden AG, van der Harst P, van der Schouw YT, Staehlin O, Vogelzangs N, Vollenweider P, Waeber G, Wareham NJ, Waterworth DM, Whitfield JB, Wichmann EH, Willemsen G, Witteman JC, Yuan X, Zhai G, Zhao JH, Zhang W, Martin NG, Metspalu A, et alSchumann G, Coin LJ, Lourdusamy A, Charoen P, Berger KH, Stacey D, Desrivières S, Aliev FA, Khan AA, Amin N, Aulchenko YS, Bakalkin G, Bakker SJ, Balkau B, Beulens JW, Bilbao A, de Boer RA, Beury D, Bots ML, Breetvelt EJ, Cauchi S, Cavalcanti-Proença C, Chambers JC, Clarke TK, Dahmen N, de Geus EJ, Dick D, Ducci F, Easton A, Edenberg HJ, Esko T, Fernández-Medarde A, Foroud T, Freimer NB, Girault JA, Grobbee DE, Guarrera S, Gudbjartsson DF, Hartikainen AL, Heath AC, Hesselbrock V, Hofman A, Hottenga JJ, Isohanni MK, Kaprio J, Khaw KT, Kuehnel B, Laitinen J, Lobbens S, Luan J, Mangino M, Maroteaux M, Matullo G, McCarthy MI, Mueller C, Navis G, Numans ME, Núñez A, Nyholt DR, Onland-Moret CN, Oostra BA, O'Reilly PF, Palkovits M, Penninx BW, Polidoro S, Pouta A, Prokopenko I, Ricceri F, Santos E, Smit JH, Soranzo N, Song K, Sovio U, Stumvoll M, Surakk I, Thorgeirsson TE, Thorsteinsdottir U, Troakes C, Tyrfingsson T, Tönjes A, Uiterwaal CS, Uitterlinden AG, van der Harst P, van der Schouw YT, Staehlin O, Vogelzangs N, Vollenweider P, Waeber G, Wareham NJ, Waterworth DM, Whitfield JB, Wichmann EH, Willemsen G, Witteman JC, Yuan X, Zhai G, Zhao JH, Zhang W, Martin NG, Metspalu A, Doering A, Scott J, Spector TD, Loos RJ, Boomsma DI, Mooser V, Peltonen L, Stefansson K, van Duijn CM, Vineis P, Sommer WH, Kooner JS, Spanagel R, Heberlein UA, Jarvelin MR, Elliott P. Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A 2011; 108:7119-24. [PMID: 21471458 PMCID: PMC3084048 DOI: 10.1073/pnas.1017288108] [Show More Authors] [Citation(s) in RCA: 211] [Impact Index Per Article: 15.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Alcohol consumption is a moderately heritable trait, but the genetic basis in humans is largely unknown, despite its clinical and societal importance. We report a genome-wide association study meta-analysis of ∼2.5 million directly genotyped or imputed SNPs with alcohol consumption (gram per day per kilogram body weight) among 12 population-based samples of European ancestry, comprising 26,316 individuals, with replication genotyping in an additional 21,185 individuals. SNP rs6943555 in autism susceptibility candidate 2 gene (AUTS2) was associated with alcohol consumption at genome-wide significance (P = 4 × 10(-8) to P = 4 × 10(-9)). We found a genotype-specific expression of AUTS2 in 96 human prefrontal cortex samples (P = 0.026) and significant (P < 0.017) differences in expression of AUTS2 in whole-brain extracts of mice selected for differences in voluntary alcohol consumption. Down-regulation of an AUTS2 homolog caused reduced alcohol sensitivity in Drosophila (P < 0.001). Our finding of a regulator of alcohol consumption adds knowledge to our understanding of genetic mechanisms influencing alcohol drinking behavior.
Collapse
Affiliation(s)
- Gunter Schumann
- Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College, London SE5 8AF, United Kingdom
| | - Lachlan J. Coin
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom
| | - Anbarasu Lourdusamy
- Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College, London SE5 8AF, United Kingdom
| | - Pimphen Charoen
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom
- Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
- Imperial College Healthcare NHS Trust Comprehensive Biomedical Research Centre, London W2 1PG, United Kingdom
| | - Karen H. Berger
- Ernest Gallo Clinic and Research Center, University of California at San Francisco, Emeryville, CA 94608
| | - David Stacey
- Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College, London SE5 8AF, United Kingdom
| | - Sylvane Desrivières
- Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College, London SE5 8AF, United Kingdom
| | | | - Anokhi A. Khan
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom
| | - Najaf Amin
- Genetic Epidemiology Unit, Department of Epidemiology and Clinical Genetics, Erasmus University Medical Centre, Rotterdam 3000CA, The Netherlands
| | - Yurii S. Aulchenko
- Genetic Epidemiology Unit, Department of Epidemiology and Clinical Genetics, Erasmus University Medical Centre, Rotterdam 3000CA, The Netherlands
| | - Georgy Bakalkin
- Department of Pharmaceutical Biosciences, Uppsala University, Uppsala 751 24, Sweden
| | - Stephan J. Bakker
- Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands
| | - Beverley Balkau
- Institut National de la Santé et de la Recherche Médicale U780, 75654 Paris, France
- University Paris-Sud, F-91405 Orsay, France
| | - Joline W. Beulens
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht 3508 GA, The Netherlands
| | - Ainhoa Bilbao
- Department of Psychopharmacology, Central Institute of Mental Health, 68159 Mannheim, Germany
| | - Rudolf A. de Boer
- Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands
| | - Delphine Beury
- Department of Genomics and Molecular Physiology of Metabolic Diseases, Centre National de la Recherche Scientifique-Unité Mixte de Recherche-8090, Institute of Biology of Lille, BP 44759021 Lille, France
| | - Michiel L. Bots
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht 3508 GA, The Netherlands
| | - Elemi J. Breetvelt
- Department of Psychiatry, Universitair Medisch Centrum Utrecht, Utrecht 3584 CX, The Netherlands
| | - Stéphane Cauchi
- Department of Genomics and Molecular Physiology of Metabolic Diseases, Centre National de la Recherche Scientifique-Unité Mixte de Recherche-8090, Institute of Biology of Lille, BP 44759021 Lille, France
| | - Christine Cavalcanti-Proença
- Department of Genomics and Molecular Physiology of Metabolic Diseases, Centre National de la Recherche Scientifique-Unité Mixte de Recherche-8090, Institute of Biology of Lille, BP 44759021 Lille, France
| | - John C. Chambers
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom
| | - Toni-Kim Clarke
- Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College, London SE5 8AF, United Kingdom
| | - Norbert Dahmen
- Department of Psychiatry and Psychotherapy, University of Mainz, 55131 Mainz, Germany
| | - Eco J. de Geus
- Indiana University, School of Medicine, Indianapolis, IN 46202-3082
| | - Danielle Dick
- Virginia Commonwealth University, Richmond, VA 23284
| | - Francesca Ducci
- Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College, London SE5 8AF, United Kingdom
| | - Alanna Easton
- Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College, London SE5 8AF, United Kingdom
| | | | - Tõnu Esko
- Department of Biotechnology, Institute of Molecular and Cell Biology, Faculty of Science and Technology, University of Tartu, Tartu 51010, Estonia
- Estonian Genome Project of University of Tartu, Tartu 50410, Estonia
- Estonian Biocentre, Tartu 51010, Estonia
| | - Alberto Fernández-Medarde
- Comision de Investigaciones Cientificas de la Provincia de Buenos Aires-Instituto de Biología Molecular y Celular del Cáncer de Salamanca, University of Salamanca–Consejo Superior de Investigaciones Cientificas (Spain), 37007 Salamanca, Spain
| | - Tatiana Foroud
- Indiana University, School of Medicine, Indianapolis, IN 46202-3082
| | - Nelson B. Freimer
- University of California Los Angeles Center for Neurobehavioural Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA 90095
| | - Jean-Antoine Girault
- Institut du Fer à Moulin, Institut National de la Santé et de la Recherche Médicale, Université Pierre et Marie Curie, 75005 Paris, France
| | - Diederick E. Grobbee
- Department of Psychopharmacology, Central Institute of Mental Health, 68159 Mannheim, Germany
| | | | - Daniel F. Gudbjartsson
- deCODE genetics, Faculty of Medicine, Reykjavik and University of Iceland, Reykjavik IS 101, Iceland
| | | | - Andrew C. Heath
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110
| | | | - Albert Hofman
- Genetic Epidemiology Unit, Department of Epidemiology and Clinical Genetics, Erasmus University Medical Centre, Rotterdam 3000CA, The Netherlands
| | - Jouke-Jan Hottenga
- Department of Biological Psychology, Vrije Universiteit and VU Medical Center, Amsterdam 1081 HV, The Netherlands
| | - Matti K. Isohanni
- Institute of Clinical Medicine, University of Oulu, FI-90014, Oulu, Finland
| | - Jaakko Kaprio
- Department of Public Health, University of Helsinki, FI-00014, Helsinki, Finland
- Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, FI-00271, Helsinki, Finland
- Institute for Molecular Medicine, FI-00014, Helsinki, Finland
| | - Kay-Tee Khaw
- Clinical Gerontology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge CB2 0SP, United Kingdom
| | - Brigitte Kuehnel
- Institute of Epidemiology, Helmholtz Zentrum, German Research Center for Environmental Health, D-85764 Neuherberg, Germany
| | - Jaana Laitinen
- Finnish Institute of Occupational Health, FI-90220, Oulu, Finland
| | - Stéphane Lobbens
- Department of Genomics and Molecular Physiology of Metabolic Diseases, Centre National de la Recherche Scientifique-Unité Mixte de Recherche-8090, Institute of Biology of Lille, BP 44759021 Lille, France
| | - Jian'an Luan
- Medical Research Council Epidemiology Unit–Institute of Metabolic Science, Cambridge CB2 0QQ, United Kingdom;
| | - Massimo Mangino
- Department of Twin Research and Genetic Epidemiology, King's College, London SE1 7EH, United Kingdom
| | - Matthieu Maroteaux
- Institut du Fer à Moulin, Institut National de la Santé et de la Recherche Médicale, Université Pierre et Marie Curie, 75005 Paris, France
| | - Giuseppe Matullo
- Institute for Scientific Information Foundation and Department of Genetics, Biology and Biochemistry, University of Turin, Turin 10126, Italy
| | - Mark I. McCarthy
- Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LJ, United Kingdom
| | - Christian Mueller
- Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College, London SE5 8AF, United Kingdom
- Department of Psychiatry and Psychotherapy, University of Erlangen-Nuernberg, 91054 Erlangen, Germany
| | - Gerjan Navis
- Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands
| | - Mattijs E. Numans
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht 3508 GA, The Netherlands
| | - Alejandro Núñez
- Comision de Investigaciones Cientificas de la Provincia de Buenos Aires-Instituto de Biología Molecular y Celular del Cáncer de Salamanca, University of Salamanca–Consejo Superior de Investigaciones Cientificas (Spain), 37007 Salamanca, Spain
| | - Dale R. Nyholt
- Queensland Institute of Medical Research, Brisbane QLD 4029, Australia
| | - Charlotte N. Onland-Moret
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht 3508 GA, The Netherlands
- Complex Genetics Section, Department of Medical Genetics–Divisie Biomedische Genetica, University Medical Center, Utrecht 3508 GA, The Netherlands
| | - Ben A. Oostra
- Department of Pharmaceutical Biosciences, Uppsala University, Uppsala 751 24, Sweden
| | - Paul F. O'Reilly
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom
| | | | - Brenda W. Penninx
- EMGO Institute for Health and Care Research, Department of Psychiatry, VU University Medical Center, Amsterdam 1081 BT, The Netherlands
- University Medical Center, Groningen 9700 RB, The Netherlands
- Leiden University Medical Center, Leiden 2333 ZA, The Netherlands
| | | | - Anneli Pouta
- National Institute for Health and Welfare, FI-90101, Oulu, Finland
| | - Inga Prokopenko
- Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LJ, United Kingdom
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, United Kingdom
| | - Fulvio Ricceri
- Institute for Scientific Interchange, Turin 10133, Italy
| | - Eugenio Santos
- Comision de Investigaciones Cientificas de la Provincia de Buenos Aires-Instituto de Biología Molecular y Celular del Cáncer de Salamanca, University of Salamanca–Consejo Superior de Investigaciones Cientificas (Spain), 37007 Salamanca, Spain
| | - Johannes H. Smit
- EMGO Institute for Health and Care Research, Department of Psychiatry, VU University Medical Center, Amsterdam 1081 BT, The Netherlands
| | - Nicole Soranzo
- Department of Twin Research and Genetic Epidemiology, King's College, London SE1 7EH, United Kingdom
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, United Kingdom
| | - Kijoung Song
- Genetics Division, Research and Development, GlaxoSmithKline, King of Prussia, PA 19406
| | - Ulla Sovio
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom
| | - Michael Stumvoll
- Department of Medicine, University of Leipzig, 04103 Leipzig, Germany
- Leipzig Research Centre for Modern Diseases (LIFE), University of Leipzig, 04103 Leipzig, Germany
| | - Ida Surakk
- Institute for Molecular Medicine, FI-00014, Helsinki, Finland
- Public Health Genomics, National Institute for Health and Welfare, FI-00271, Helsinki, Finland
| | - Thorgeir E. Thorgeirsson
- deCODE genetics, Faculty of Medicine, Reykjavik and University of Iceland, Reykjavik IS 101, Iceland
| | - Unnur Thorsteinsdottir
- deCODE genetics, Faculty of Medicine, Reykjavik and University of Iceland, Reykjavik IS 101, Iceland
| | - Claire Troakes
- Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College, London SE5 8AF, United Kingdom
| | - Thorarinn Tyrfingsson
- Vogur Samtök áhugafólks um áfengis Addiction Treatment Center, Reykjavik 112, Iceland
| | - Anke Tönjes
- Department of Medicine, University of Leipzig, 04103 Leipzig, Germany
- University of Leipzig, Coordination Centre for Clinical Trials, 04317 Leipzig, Germany
| | - Cuno S. Uiterwaal
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht 3508 GA, The Netherlands
| | - Andre G. Uitterlinden
- Department of Internal Medicine, Erasmus University Medical Center, Rotterdam 3015 CE, The Netherlands
| | - Pim van der Harst
- Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen 9700 RB, The Netherlands
| | - Yvonne T. van der Schouw
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht 3508 GA, The Netherlands
| | - Oliver Staehlin
- Department of Psychopharmacology, Central Institute of Mental Health, 68159 Mannheim, Germany
| | - Nicole Vogelzangs
- EMGO Institute for Health and Care Research, Department of Psychiatry, VU University Medical Center, Amsterdam 1081 BT, The Netherlands
| | - Peter Vollenweider
- Department of Medicine, Centre Hospitalier Universitaire Vaudois University Hospital, CH-1011 Lausanne, Switzerland
| | - Gerard Waeber
- Department of Medicine, Centre Hospitalier Universitaire Vaudois University Hospital, CH-1011 Lausanne, Switzerland
| | - Nicholas J. Wareham
- Medical Research Council Epidemiology Unit–Institute of Metabolic Science, Cambridge CB2 0QQ, United Kingdom;
| | - Dawn M. Waterworth
- Genetics Division, Research and Development, GlaxoSmithKline, King of Prussia, PA 19406
| | - John B. Whitfield
- Queensland Institute of Medical Research, Brisbane QLD 4029, Australia
| | - Erich H. Wichmann
- Institute of Epidemiology, Helmholtz Zentrum, German Research Center for Environmental Health, D-85764 Neuherberg, Germany
- Institute of Medical Informatics, Biometry and Epidemiology, Ludwig Maximilians University, D-80336 Munich, Germany
- Klinikum Grosshadern, D-81377 Munich, Germany
| | - Gonneke Willemsen
- Department of Biological Psychology, Vrije Universiteit and VU Medical Center, Amsterdam 1081 HV, The Netherlands
| | - Jacqueline C. Witteman
- Department of Epidemiology, Erasmus University Medical Center, Rotterdam 3015 GE, The Netherlands
| | - Xin Yuan
- Genetics Division, Research and Development, GlaxoSmithKline, King of Prussia, PA 19406
| | - Guangju Zhai
- Department of Twin Research and Genetic Epidemiology, King's College, London SE1 7EH, United Kingdom
| | - Jing H. Zhao
- Medical Research Council Epidemiology Unit–Institute of Metabolic Science, Cambridge CB2 0QQ, United Kingdom;
| | - Weihua Zhang
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom
| | | | - Andres Metspalu
- Department of Biotechnology, Institute of Molecular and Cell Biology, Faculty of Science and Technology, University of Tartu, Tartu 51010, Estonia
- Estonian Genome Project of University of Tartu, Tartu 50410, Estonia
- Estonian Biocentre, Tartu 51010, Estonia
| | - Angela Doering
- Institute of Epidemiology, Helmholtz Zentrum, German Research Center for Environmental Health, D-85764 Neuherberg, Germany
| | - James Scott
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom
| | - Tim D. Spector
- Department of Twin Research and Genetic Epidemiology, King's College, London SE1 7EH, United Kingdom
| | - Ruth J. Loos
- Medical Research Council Epidemiology Unit–Institute of Metabolic Science, Cambridge CB2 0QQ, United Kingdom;
| | - Dorret I. Boomsma
- Department of Biological Psychology, Vrije Universiteit and VU Medical Center, Amsterdam 1081 HV, The Netherlands
| | - Vincent Mooser
- Genetics Division, Research and Development, GlaxoSmithKline, King of Prussia, PA 19406
| | - Leena Peltonen
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, United Kingdom
- Institute for Molecular Medicine Finland (FIMM), Nordic European Molecular Biology Laboratory Partnership for Molecular Medicine, Biomedicum Helsinki 2U, University of Helsinki and National Institute for Health and Welfare, FI-00014, Helsinki, Finland
| | - Kari Stefansson
- deCODE genetics, Faculty of Medicine, Reykjavik and University of Iceland, Reykjavik IS 101, Iceland
| | - Cornelia M. van Duijn
- Genetic Epidemiology Unit, Department of Epidemiology and Clinical Genetics, Erasmus University Medical Centre, Rotterdam 3000CA, The Netherlands
| | - Paolo Vineis
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom
- Institute for Scientific Interchange, Turin 10133, Italy
| | - Wolfgang H. Sommer
- Department of Psychopharmacology, Central Institute of Mental Health, 68159 Mannheim, Germany
| | - Jaspal S. Kooner
- Faculty of Medicine, National Heart and Lung Institute, Cardiovascular Science, Hammersmith Hospital, Hammersmith Campus, Imperial College London, London W12 0NN, United Kingdom
| | - Rainer Spanagel
- Department of Psychopharmacology, Central Institute of Mental Health, 68159 Mannheim, Germany
| | - Ulrike A. Heberlein
- Ernest Gallo Clinic and Research Center, University of California at San Francisco, Emeryville, CA 94608
| | - Marjo-Riitta Jarvelin
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom
- National Institute for Health and Welfare, FI-90101, Oulu, Finland
- Institute of Health Sciences, University of Oulu, FI-90014, Oulu, Finland
- Biocenter Oulu, University of Oulu, FI-90014, Oulu, Finland; and
| | - Paul Elliott
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom
- Medical Research Council-Health Protection Agency Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London W2 1PG, United Kingdom
| |
Collapse
|
268
|
Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, Roerecke M. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 2011; 29:437-45. [PMID: 20636661 DOI: 10.1111/j.1465-3362.2009.00153.x] [Citation(s) in RCA: 438] [Impact Index Per Article: 31.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
INTRODUCTION AND AIMS Alcohol is an established risk factor for liver cirrhosis. It remains unclear, however, whether this relationship follows a continuous dose-response pattern or has a threshold. Also, the influences of sex and end-point (i.e. mortality vs. morbidity) on the association are not known. To address these questions and to provide a quantitative assessment of the association between alcohol intake and risk of liver cirrhosis, we conducted a systematic review and meta-analysis of cohort and case-control studies. DESIGN AND METHODS Studies were identified by a literature search of Ovid MEDLINE, EMBASE, Web of Science, CINAHL, PsychINFO, ETOH and Google Scholar from January 1980 to January 2008 and by searching the references of retrieved articles. Studies were included if quantifiable information on risk and related confidence intervals with respect to at least three different levels of average alcohol intake were reported. Both categorical and continuous meta-analytic techniques were used to model the dose-response relationship. RESULTS Seventeen studies met the inclusion criteria. We found some indications for threshold effects. Alcohol consumption had a significantly larger impact on mortality of liver cirrhosis compared with morbidity. Also, the same amount of average consumption was related to a higher risk of liver cirrhosis in women than in men. DISCUSSION AND CONCLUSIONS Overall, end-point was an important source of heterogeneity among study results. This result has important implications not only for studies in which the burden of disease attributable to alcohol consumption is estimated, but also for prevention.
Collapse
Affiliation(s)
- Jürgen Rehm
- Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Ontario, Canada.
| | | | | | | | | | | | | |
Collapse
|
269
|
Kerr WC, Ye Y. Relationship of life-course drinking patterns to diabetes, heart problems, and hypertension among those 40 and older in the 2005 U.S. National Alcohol Survey. J Stud Alcohol Drugs 2011; 71:515-25. [PMID: 20553659 DOI: 10.15288/jsad.2010.71.515] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
OBJECTIVE The goal of this study was to estimate relationships between life-course drinking patterns and the risks of self-reported diabetes, heart problems, and hypertension. METHOD Respondents to the 2005 National Alcohol Survey, age 40 and older, reported ever having a doctor or health professional diagnose each of the health-problem outcomes. Retrospective earlier-life drinking patterns were characterized by lifetime abstention and the frequency of 5+ drinking days (i.e., days on which five or more drinks were consumed) in the respondent's teens, 20s, and 30s. Past-year drinking patterns were measured through intake volume and 5+ days. Potential confounders in the domains of demographics, socioeconomic resources, and other health-risk variables-that is, depression, distress, sense of coherence, body mass index, tobacco use, marijuana use, childhood abuse, and family history of alcohol problems--were controlled through propensity-score matching. RESULTS After matching, lifetime abstainers were found to be at increased risk of diabetes compared with both lifetime and current moderate drinkers. Exdrinkers were found to be at increased risk of diabetes, heart problems, and hypertension. Higher volume drinkers without monthly 5+ days were found to be at reduced risk of diabetes relative to moderate-volume current drinkers. Heavy-occasion drinkers were found to be at increased risk of hypertension. CONCLUSIONS Regular lower quantity alcohol intake may be protective against adult onset of diabetes, but no evidence of protection from heart problems or hypertension was found. Both life course-defined and past year-defined drinking groups exhibit substantial clustering of confounding risk variables, indicating the need for modeling strategies like propensity-score matching. Increased risks among exdrinkers suggest a substantial "sick-quitter" effect.
Collapse
Affiliation(s)
- William C Kerr
- Alcohol Research Group, 6475 Christie Avenue, Suite 400, Emeryville, California 94608, USA.
| | | |
Collapse
|
270
|
Kerr WC, Karriker-Jaffe K, Subbaraman M, Ye Y. Per capita alcohol consumption and ischemic heart disease mortality in a panel of US states from 1950 to 2002. Addiction 2011; 106:313-22. [PMID: 21059185 PMCID: PMC3058887 DOI: 10.1111/j.1360-0443.2010.03195.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
AIMS To estimate the overall impact of alcohol on ischemic heart disease (IHD) mortality in the United States using aggregate-level models and to consider beverage-specific effects that may represent more effectively the changes in drinking patterns over time that are related to both harmful and protective impacts of alcohol consumption on IHD. DESIGN Several model specifications are estimated, including state-specific autoregressive integrated moving average (ARIMA) models and generalized least squares (GLS) panel models on first-differenced data. SETTING US states from 1950 to 2002. PARTICIPANTS US general population. MEASUREMENTS Per capita alcohol sales and cigarette sales, age-standardized IHD and cirrhosis mortality rates. FINDINGS Apparent consumption of total alcohol was associated with a significant overall increase of IHD of about 1% mortality per litre of ethanol. Beverage-specific models found that spirits consumption was significantly positively related to IHD mortality overall, for both genders and in three regions defined by drinking culture (or 'wetness'), while beer was found to have a significant protective relationship overall and in the wet region. The results for wine also suggest a protective relationship, but only marginally significant effects were found. Cirrhosis mortality rates were consistently positively related to IHD mortality. Combined results from state-specific ARIMA models including both cigarette sales and cirrhosis rates were generally consistent with the GLS results. CONCLUSIONS Population-level models confirm individual-level findings of both harmful and protective relationships between alcohol use patterns and ischemic heart disease mortality. However, an overall harmful impact of per capita alcohol consumption on IHD mortality was found.
Collapse
|
271
|
Roerecke M, Rehm J. Ischemic heart disease mortality and morbidity rates in former drinkers: a meta-analysis. Am J Epidemiol 2011; 173:245-58. [PMID: 21156750 DOI: 10.1093/aje/kwq364] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
Current abstainers from alcohol have been identified as an inadequate reference group in epidemiologic studies of the effects of alcohol, because inclusion of former drinkers might lead to overestimation of the protective effects and underestimation of the detrimental effects of drinking alcohol. The authors' objective in the current study was to quantify this association for ischemic heart disease (IHD). Electronic databases were systematically searched for relevant case-control or cohort studies published from 1980 to 2010. Thirty-eight articles fulfilled the inclusion criteria, contributing a total of 5,613 IHD events and 12,097 controls among case-control studies and 1,387 events with combined endpoints and 7,183 events stratified by endpoint among 232,621 persons at risk among cohort studies. Pooled estimates for the subset stratified by sex and endpoint showed a significantly increased risk among former drinkers compared with long-term abstainers for IHD mortality ( among men; relative risk = 1.25, 95% confidence interval: 1.15, 1.36; among women relative risk = 1.54, 95% confidence interval: 1.17, 2.03). For IHD morbidity, the estimates for both sexes were close to unity and not statistically significant. Results were robust in several sensitivity analyses. In future studies, researchers should separate former drinkers from the reference category to obtain unbiased effect estimates. Implications for the overall beneficial and detrimental effects of alcohol consumption on IHD are discussed below.
Collapse
Affiliation(s)
- Michael Roerecke
- Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
| | | |
Collapse
|
272
|
Abstract
OBJECTIVES Valsalva maneuver-associated activities such as straining during defecation, vomiting, and cough are believed to cause abrupt increase in variceal pressure. Whether these actions can precipitate rupture of esophageal varices (EV) is unknown. The association of EV bleeding with these activities and other potential risk factors such as ingestion of alcohol and non-steroidal anti-inflammatory drugs was investigated. METHODS Between January 2003 and May 2009, 240 patients with liver cirrhosis and acute EV bleeding (group A) and 240 matched patients with Child-Pugh's class and moderate size EV without bleeding (group B) were included. Each patient was questioned regarding constipation, vomiting, cough, and other potential risk factors in the week prior to index bleeding (group A) or endoscopy (group B) using a standard questionnaire. RESULTS Group A had more patients with constipation (n=44 vs. n=16, P<0.001) and higher constipation scores (0.79 ± 1.67 vs. 0.25 ± 0.92, P<0.001) than group B. Group A also had more patients with vomiting (n=60 vs. n=33, P=0.002) and higher vomiting scores (3.0 ± 0.86 vs. 1.85 ± 0.87, P<0.001). No difference in cough existed between the two groups (n=77 group A vs. n=73 group B); however, group A had higher cough scores (5.08 ± 2.70 vs. 3.19 ± 2.23, P<0.001). Group A had more patients with excessive alcohol consumption in the week preceding inclusion in the study (n=58 vs. n=5, P<0.001). On multivariate analysis, constipation score and vomiting score and alcohol consumption were independent determinants of first EV bleeding. CONCLUSIONS Constipation, vomiting, severe coughing, and excessive consumption of alcohol may precipitate rupture of EV. A prospective cohort study is required to clarify the causal relationship between potential precipitating factors and EV bleeding.
Collapse
|
273
|
Abstract
AIMS This study investigated the association between alcohol consumption and health status using cross-sectional national survey data. MEASUREMENTS AND DESIGN: This study relied upon self-report data collected by the 2004 and 2007 Australian National Drug Strategy Household (NDSH) surveys. Households were selected using a multi-stage, stratified-area, random sample design. Both surveys used combinations of the drop-and-collect and computer-assisted telephone interview approaches. Respondents were questioned about their current and past drinking, the presence of formal diagnosis for specific diseases (heart disease, type 2 diabetes, hypertension, cancer, anxiety, depression) and self-perceived general health status. Associations between drinking status, the presence of diagnoses and self-perceptions of general health status among respondents aged 18+ and 45+ were assessed using multivariate logistic regression. SETTING AND PARTICIPANTS Males and females aged 18 years or older and resident in Australia. The sample sizes for the 2004 and 2007 NDSH surveys were 24, 109 and 23, 356, respectively. FINDINGS Respondents with a diagnosis of diabetes, hypertension and anxiety were more likely to have reduced or stopped alcohol consumption in the past 12 months. The likelihood of having reduced or ceased alcohol consumption in the past 12 months increased as perceived general health status declined from excellent to poor. CONCLUSIONS Experience of ill health is associated with subsequent reduction or cessation of alcohol consumption. This may at least partly underlie the observed 'J-shape' function relating alcohol consumption to premature mortality.
Collapse
Affiliation(s)
- Wenbin Liang
- National Drug Research Institute, Curtin University of Technology, Perth, Western Australia, Australia.
| | | |
Collapse
|
274
|
Greenfield TK, Kerr WC. Commentary on Liang & Chikritzhs (2011): Quantifying the impacts of health problems on drinking and subsequent morbidity and mortality – life-course measures are essential. Addiction 2011; 106:82-3. [PMID: 21618726 DOI: 10.1111/j.1360-0443.2010.03298.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Thomas K Greenfield
- Public Health Institute—Alcohol Research Group, 6475Christie Ave., Suite 400 Emeryville, CA 94608, USA.E-mail:
| | | |
Collapse
|
275
|
McGue M, Osler M, Christensen K. Causal Inference and Observational Research: The Utility of Twins. PERSPECTIVES ON PSYCHOLOGICAL SCIENCE 2010; 5:546-56. [PMID: 21593989 PMCID: PMC3094752 DOI: 10.1177/1745691610383511] [Citation(s) in RCA: 370] [Impact Index Per Article: 24.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Valid causal inference is central to progress in theoretical and applied psychology. Although the randomized experiment is widely considered the gold standard for determining whether a given exposure increases the likelihood of some specified outcome, experiments are not always feasible and in some cases can result in biased estimates of causal effects. Alternatively, standard observational approaches are limited by the possibility of confounding, reverse causation, and the nonrandom distribution of exposure (i.e., selection). We describe the counterfactual model of causation and apply it to the challenges of causal inference in observational research, with a particular focus on aging. We argue that the study of twin pairs discordant on exposure, and in particular discordant monozygotic twins, provides a useful analog to the idealized counterfactual design. A review of discordant-twin studies in aging reveals that they are consistent with, but do not unambiguously establish, a causal effect of lifestyle factors on important late-life outcomes. Nonetheless, the existing studies are few in number and have clear limitations that have not always been considered in interpreting their results. It is concluded that twin researchers could make greater use of the discordant-twin design as one approach to strengthen causal inferences in observational research.
Collapse
Affiliation(s)
- Matt McGue
- Department of Psychology, University of Minnesota, Minneapolis Institute of Public Health, University of Southern Denmark, Odense, Denmark
| | - Merete Osler
- Institute of Public Health, University of Southern Denmark, Odense, Denmark Research Center for Prevention and Health, Glostrup Hospital, Glostrup, Denmark
| | - Kaare Christensen
- The Danish Twin Registry and The Danish Aging Research Center Institute of Public Health, University of Southern Denmark, Odense, Denmark
| |
Collapse
|
276
|
Samet JH, Pace CA, Cheng DM, Coleman S, Bridden C, Pardesi M, Saggurti N, Raj A. Alcohol use and sex risk behaviors among HIV-infected female sex workers (FSWs) and HIV-infected male clients of FSWs in India. AIDS Behav 2010; 14 Suppl 1:S74-83. [PMID: 20544381 PMCID: PMC2953370 DOI: 10.1007/s10461-010-9723-y] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Unprotected heterosexual transactional sex plays a central role in the spread of HIV in India. Given alcohol's association with risky sex in other populations and alcohol's role in HIV disease progression, we investigated patterns of alcohol use in HIV-infected female sex workers (FSWs) and HIV-infected male clients of FSWs in Mumbai. Analyses identified factors associated with heavy alcohol use and evaluated the relationship between alcohol use and risky sex. We surveyed 211 female and 205 male individuals; 80/211 FSWs (38%) and 127/205 male clients (62%) drank alcohol in the last 30 days. Among females, 32 and 11% drank heavily and were alcohol-dependent, respectively; among males the respective proportions were 44 and 29%. Men's heavy alcohol use was significantly associated with inconsistent condom use over the last year (AOR 2.40, 95% CI 1.21-4.77, P = 0.01); a comparable association was not seen in women. These findings suggest a need to address alcohol use both to avoid the medical complications of its heavy use in this population and to mitigate inconsistent condom use, the latter issue possibly requiring gender specific approaches. Such efforts to reduce drinking will be an important dimension to secondary HIV prevention in India.
Collapse
Affiliation(s)
- Jeffrey H Samet
- Department of Medicine, Section of General Internal Medicine, Clinical Addiction Research and Education Unit, Boston University School of Medicine/Boston Medical Center, 801 Massachusetts Ave, 2nd Floor, Boston, MA 02118, USA.
| | | | | | | | | | | | | | | |
Collapse
|
277
|
McCaul KA, Almeida OP, Hankey GJ, Jamrozik K, Byles JE, Flicker L. Alcohol use and mortality in older men and women. Addiction 2010; 105:1391-400. [PMID: 20528808 DOI: 10.1111/j.1360-0443.2010.02972.x] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
AIMS To compare the effect of alcohol intake on 10-year mortality for men and women over the age of 65 years. DESIGN, SETTING AND PARTICIPANTS Two prospective cohorts of community-dwelling men aged 65-79 years at baseline in 1996 (n = 11 727) and women aged 70-75 years in 1996 (n = 12 432). MEASUREMENTS Alcohol was assessed according to frequency of use (number of days alcohol was consumed per week) and quantity consumed per day. Cox proportional hazards models were compared for men and women for all-cause and cause-specific mortality. FINDINGS Compared with older adults who did not consume alcohol every week, the risk of all-cause mortality was reduced in men reporting up to four standard drinks per day and in women who consumed one or two drinks per day. One or two alcohol-free days per week reduced this risk further in men, but not in women. Similar results were observed for deaths due to cardiovascular disease. CONCLUSIONS In people over the age of 65 years, alcohol intake of four standard drinks per day for men and two standard drinks per day for women was associated with lower mortality risk. For men, the risk was reduced further if accompanied with 1 or 2 alcohol-free days per week.
Collapse
Affiliation(s)
- Kieran A McCaul
- Western Australian Centre for Health and Ageing, University of Western Australia, 35 Stirling Highway, Crawley, Western Australia 6009, Australia.
| | | | | | | | | | | |
Collapse
|
278
|
Joosten MM, Grobbee DE, van der A DL, Verschuren WMM, Hendriks HFJ, Beulens JWJ. Combined effect of alcohol consumption and lifestyle behaviors on risk of type 2 diabetes. Am J Clin Nutr 2010; 91:1777-83. [PMID: 20410096 DOI: 10.3945/ajcn.2010.29170] [Citation(s) in RCA: 61] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND It has been suggested that the inverse association between alcohol and type 2 diabetes could be explained by moderate drinkers' healthier lifestyles. OBJECTIVE We studied whether moderate alcohol consumption is associated with a lower risk of type 2 diabetes in adults with combined low-risk lifestyle behaviors. DESIGN We prospectively examined 35,625 adults of the Dutch European Prospective Investigation into Cancer and Nutrition (EPIC-NL) cohort aged 20-70 y, who were free of diabetes, cardiovascular disease, and cancer at baseline (1993-1997). In addition to moderate alcohol consumption (women: 5.0-14.9 g/d; men: 5.0-29.9 g/d), we defined low-risk categories of 4 lifestyle behaviors: optimal weight [body mass index (in kg/m(2)) <25], physically active (> or =30 min of physical activity/d), current nonsmoker, and a healthy diet [upper 2 quintiles of the Dietary Approaches to Stop Hypertension (DASH) diet]. RESULTS During a median of 10.3 y, we identified 796 incident cases of type 2 diabetes. Compared with teetotalers, hazard ratios of moderate alcohol consumers for risk of type 2 diabetes in low-risk lifestyle strata after multivariable adjustments were 0.35 (95% CI: 0.17, 0.72) when of a normal weight, 0.65 (95% CI: 0.46, 0.91) when physically active, 0.54 (95% CI: 0.41, 0.71) when nonsmoking, and 0.57 (95% CI: 0.39, 0.84) when consuming a healthy diet. When > or =3 low-risk lifestyle behaviors were combined, the hazard ratio for incidence of type 2 diabetes in moderate alcohol consumers after multivariable adjustments was 0.56 (95% CI: 0.32, 1.00). CONCLUSION In subjects already at lower risk of type 2 diabetes on the basis of multiple low-risk lifestyle behaviors, moderate alcohol consumption was associated with an approximately 40% lower risk compared with abstention.
Collapse
Affiliation(s)
- Michel M Joosten
- TNO Quality of Life, Business Unit Biosciences, Zeist, Netherlands
| | | | | | | | | | | |
Collapse
|
279
|
Rey G, Boniol M, Jougla E. Estimating the number of alcohol-attributable deaths: methodological issues and illustration with French data for 2006. Addiction 2010; 105:1018-29. [PMID: 20331552 DOI: 10.1111/j.1360-0443.2010.02910.x] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
AIMS Computing the number of alcohol-attributable deaths requires a series of hypotheses. Using French data for 2006, the potential biases are reviewed and the sensitivity of estimates to various hypotheses evaluated. METHODS Self-reported alcohol consumption data were derived from large population-based surveys. The risks of occurrence of diseases associated with alcohol consumption and relative risks for all-cause mortality were obtained through literature searches. All-cause and cause-specific population alcohol-attributable fractions (PAAFs) were calculated. In order to account for potential under-reporting, the impact of adjustment on sales data was tested. The 2006 mortality data were restricted to people aged between 15 and 75 years. RESULTS When alcohol consumption distribution was adjusted for sales data, the estimated number of alcohol-attributable deaths, the sum of the cause-specific estimates, was 20 255. Without adjustment, the estimate fell to 7158. Using an all-cause mortality approach, the adjusted number of alcohol-attributable deaths was 15 950, while the non-adjusted estimate was a negative number. Other methodological issues, such as computation based on risk estimates for all causes for 'all countries' or only 'European countries', also influenced the results, but to a lesser extent. DISCUSSION The estimates of the number of alcohol-attributable deaths varied greatly, depending upon the hypothesis used. The most realistic and evidence-based estimate seems to be obtained by adjusting the consumption data for national alcohol sales, and by summing the cause-specific estimates. However, interpretation of the estimates must be cautious in view of their potentially large imprecision.
Collapse
Affiliation(s)
- Grégoire Rey
- INSERM, CépiDc, Université Paris Sud 11, IFR69 Le Vésinet, France.
| | | | | |
Collapse
|
280
|
Relationship between alcohol intake, health and social status and cardiovascular risk factors in the urban Paris-Ile-De-France Cohort: is the cardioprotective action of alcohol a myth? Eur J Clin Nutr 2010; 64:561-8. [DOI: 10.1038/ejcn.2010.61] [Citation(s) in RCA: 75] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
281
|
Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, Rehm J. Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis. BMC Public Health 2010; 10:258. [PMID: 20482788 PMCID: PMC2888740 DOI: 10.1186/1471-2458-10-258] [Citation(s) in RCA: 258] [Impact Index Per Article: 17.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2009] [Accepted: 05/18/2010] [Indexed: 01/16/2023] Open
Abstract
BACKGROUND Observational studies have suggested a complex relationship between alcohol consumption and stroke, dependent on sex, type of stroke and outcome (morbidity vs. mortality). We undertook a systematic review and a meta-analysis of studies assessing the association between levels of average alcohol consumption and relative risks of ischemic and hemorrhagic strokes separately by sex and outcome. This meta-analysis is the first to explicitly separate morbidity and mortality of alcohol-attributable stroke and thus has implications for public health and prevention. METHODS Using Medical Subject Headings (alcohol drinking, ethanol, cerebrovascular accident, cerebrovascular disorders, and intracranial embolism and thrombosis and the key word stroke), a literature search of MEDLINE, EMBASE, CINAHL, CABS, WHOlist, SIGLE, ETOH, and Web of Science databases between 1980 to June 2009 was performed followed by manual searches of bibliographies of key retrieved articles. From twenty-six observational studies (cohort or case-control) with ischemic or hemorrhagic strokes the relative risk or odds ratios or hazard ratios of stroke associated with alcohol consumption were reported; alcohol consumption was quantified; and life time abstention (manually estimated where data for current abstainers were given) was used as the reference group. Two reviewers independently extracted the information on study design, participant characteristics, level of alcohol consumption, stroke outcome, control for potential confounding factors, risk estimates and key criteria of study quality using a standardized protocol. RESULTS The dose-response relationship for hemorrhagic stroke had monotonically increasing risk for increasing consumption, whereas ischemic stroke showed a curvilinear relationship, with a protective effect of alcohol for low to moderate consumption, and increased risk for higher exposure. For more than 3 drinks on average/day, in general women had higher risks than men, and the risks for mortality were higher compared to the risks for morbidity. CONCLUSIONS These results indicate that heavy alcohol consumption increases the relative risk of any stroke while light or moderate alcohol consumption may be protective against ischemic stroke. Preventive measures that should be initiated are discussed.
Collapse
Affiliation(s)
- Jayadeep Patra
- Centre for Addiction and Mental Health, Toronto, Ontario Canada.
| | | | | | | | | | | | | |
Collapse
|
282
|
Rehm J, Baliunas D, Borges GLG, Graham K, Irving H, Kehoe T, Parry CD, Patra J, Popova S, Poznyak V, Roerecke M, Room R, Samokhvalov AV, Taylor B. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction 2010; 105:817-43. [PMID: 20331573 PMCID: PMC3306013 DOI: 10.1111/j.1360-0443.2010.02899.x] [Citation(s) in RCA: 754] [Impact Index Per Article: 50.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
AIMS As part of a larger study to estimate the global burden of disease and injury attributable to alcohol: to evaluate the evidence for a causal impact of average volume of alcohol consumption and pattern of drinking on diseases and injuries; to quantify relationships identified as causal based on published meta-analyses; to separate the impact on mortality versus morbidity where possible; and to assess the impact of the quality of alcohol on burden of disease. METHODS Systematic literature reviews were used to identify alcohol-related diseases, birth complications and injuries using standard epidemiological criteria to determine causality. The extent of the risk relations was taken from meta-analyses. RESULTS Evidence of a causal impact of average volume of alcohol consumption was found for the following major diseases: tuberculosis, mouth, nasopharynx, other pharynx and oropharynx cancer, oesophageal cancer, colon and rectum cancer, liver cancer, female breast cancer, diabetes mellitus, alcohol use disorders, unipolar depressive disorders, epilepsy, hypertensive heart disease, ischaemic heart disease (IHD), ischaemic and haemorrhagic stroke, conduction disorders and other dysrhythmias, lower respiratory infections (pneumonia), cirrhosis of the liver, preterm birth complications and fetal alcohol syndrome. Dose-response relationships could be quantified for all disease categories except for depressive disorders, with the relative risk increasing with increased level of alcohol consumption for most diseases. Both average volume and drinking pattern were linked causally to IHD, fetal alcohol syndrome and unintentional and intentional injuries. For IHD, ischaemic stroke and diabetes mellitus beneficial effects were observed for patterns of light to moderate drinking without heavy drinking occasions (as defined by 60+ g pure alcohol per day). For several disease and injury categories, the effects were stronger on mortality compared to morbidity. There was insufficient evidence to establish whether quality of alcohol had a major impact on disease burden. CONCLUSIONS Overall, these findings indicate that alcohol impacts many disease outcomes causally, both chronic and acute, and injuries. In addition, a pattern of heavy episodic drinking increases risk for some disease and all injury outcomes. Future studies need to address a number of methodological issues, especially the differential role of average volume versus drinking pattern, in order to obtain more accurate risk estimates and to understand more clearly the nature of alcohol-disease relationships.
Collapse
Affiliation(s)
- Jürgen Rehm
- Centre for Addiction and Mental Health, Toronto, Canada.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
283
|
Fillmore KM, Chikritzhs T. Commentary on Britton et al. (2010): The dangers of declining drink. Addiction 2010; 105:646-7; discussion 647-8. [PMID: 20403016 DOI: 10.1111/j.1360-0443.2009.02895.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
284
|
Breslow RA, Guenther PM, Juan W, Graubard BI. Alcoholic beverage consumption, nutrient intakes, and diet quality in the US adult population, 1999-2006. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION 2010; 110:551-62. [PMID: 20338281 PMCID: PMC2864068 DOI: 10.1016/j.jada.2009.12.026] [Citation(s) in RCA: 95] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 03/20/2009] [Accepted: 10/16/2009] [Indexed: 01/13/2023]
Abstract
BACKGROUND Little is known about associations between alcoholic beverage consumption, nutrient intakes, and diet quality, although each has been independently associated with chronic disease outcomes. OBJECTIVE This study examines cross-sectional relationships between alcoholic beverage consumption, nutrient intakes, and diet quality (Healthy Eating Index-2005 [HEI-2005] scores) in the US adult population. METHODS Data were from four cycles of the National Health and Nutrition Examination Survey (1999-2006). Weighted multiple regression analyses, adjusted for age, race/ethnicity, education, smoking status, and body mass index included 8,155 men and 7,715 women aged >or=20 years who reported their past-year alcoholic beverage consumption and 24-hour dietary intake. Alcoholic beverage consumption was defined by drinking status (never, former, current drinker) and, among current drinkers, by drinking level (number of drinks per day, on average: men <1 to >or=5; women <1 to >or=3). RESULTS Among men, there was no association between drinking status and intakes of energy, most nutrients, or total HEI-2005 score. Among women, former and current (compared to never) drinkers had significantly higher intakes of energy and several nutrients, and current drinkers had significantly lower total HEI-2005 scores (current drinkers 58.9; never drinkers 63.2). Among current drinkers of both sexes, as drinking level increased, intakes of energy and several nutrients significantly increased, whereas total HEI-2005 scores significantly decreased (from 55.9 to 41.5 in men, and from 59.5 to 51.8 in women). CONCLUSIONS Among men and women, increasing alcoholic beverage consumption was associated with a decline in total diet quality as measured by the HEI-2005, apparently due to higher energy intake from alcohol as well as other differences in food choices. Educational messages should focus on nutrition and chronic disease risk associated with high consumption of alcoholic beverages and poor food choices, including excessive energy intake.
Collapse
Affiliation(s)
- Rosalind A Breslow
- National Institute on Alcohol Abuse and Alcoholism, Division of Epidemiology and Prevention Research, 5635 Fishers Ln, Rm 2071, Rockville, MD 20892, USA.
| | | | | | | |
Collapse
|
285
|
Roerecke M, Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Epidemiol 2010; 171:633-44. [PMID: 20142394 DOI: 10.1093/aje/kwp451] [Citation(s) in RCA: 202] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Contrary to a cardioprotective effect of moderate regular alcohol consumption, accumulating evidence points to a detrimental effect of irregular heavy drinking occasions (>60 g of pure alcohol or > or =5 drinks per occasion at least monthly) on ischemic heart disease risk, even for drinkers whose average consumption is moderate. The authors systematically searched electronic databases from 1980 to 2009 for case-control or cohort studies examining the association of irregular heavy drinking occasions with ischemic heart disease risk. Studies were included if they reported either a relative risk estimate for intoxication or frequency of > or =5 drinks stratified by or adjusted for total average alcohol consumption. The search identified 14 studies (including 31 risk estimates) containing 4,718 ischemic heart disease events (morbidity and mortality). Using a standardized protocol, the authors extracted relative risk estimates and their variance, in addition to study characteristics. In a random-effects model, the pooled relative risk of irregular heavy drinking occasions compared with regular moderate drinking was 1.45 (95% confidence interval: 1.24, 1.70), with significant between-study heterogeneity (I(2) = 53.9%). Results were robust in several sensitivity analyses. The authors concluded that the cardioprotective effect of moderate alcohol consumption disappears when, on average, light to moderate drinking is mixed with irregular heavy drinking occasions.
Collapse
Affiliation(s)
- Michael Roerecke
- Centre for Addiction and Mental Health, Public Health and Regulatory Policies Section, Toronto, Ontario, Canada M5S 2S1.
| | | |
Collapse
|
286
|
Dam-Larsen S, Becker U, Franzmann MB, Larsen K, Christoffersen P, Bendtsen F. Final results of a long-term, clinical follow-up in fatty liver patients. Scand J Gastroenterol 2010; 44:1236-43. [PMID: 19670076 DOI: 10.1080/00365520903171284] [Citation(s) in RCA: 139] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVE There is increasing focus on non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to conduct a long-term clinical follow-up of patients with biopsy-confirmed fatty liver without inflammation or significant fibrosis (pure fatty liver), to analyse for potential risk factors at the time of index liver biopsy important for survival and the development of cirrhosis and to describe the causes of death. MATERIAL AND METHODS Patients were linked through their personal identification number to the Danish National Registry of Patients and the Register of Causes of Death. All admissions, discharge diagnoses and causes of death during follow-up were collected. All surviving patients were invited to a clinical follow-up. RESULTS The follow-up period was 20.4 and 21.0 years, respectively, for the NAFLD and alcoholic fatty liver disease (AFLD) groups. Two NAFLD patients (1.2%) developed cirrhosis during the follow-up period versus 54 (22%) AFLD patients. Sixty-four percent of 178 surviving patients out of an original cohort of 417 patients attended the clinical follow-up. In NAFLD patients, none of the risk factors studied was significant in relation to the risk of death. Patients with AFLD died primarily from cirrhosis and other alcohol-related disorders, whereas in patients with NAFLD the main causes of death were cardiovascular disease and cancer. CONCLUSIONS For patients with pure non-alcoholic fatty liver, survival was good and independent of the histological, clinical and biochemical characteristics at the time of biopsy; the main causes of death were cardiovascular disease and cancer.
Collapse
Affiliation(s)
- Sanne Dam-Larsen
- Gastroenterology Unit, Medical Section, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark.
| | | | | | | | | | | |
Collapse
|
287
|
Klatsky AL. Alcohol and Cardiovascular Mortality. J Am Coll Cardiol 2010; 55:1336-8. [DOI: 10.1016/j.jacc.2009.10.057] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/05/2009] [Accepted: 10/13/2009] [Indexed: 01/16/2023]
|
288
|
Roy A, Prabhakaran D, Jeemon P, Thankappan KR, Mohan V, Ramakrishnan L, Joshi P, Ahmed F, Mohan BVM, Saran RK, Sinha N, Reddy KS. Impact of alcohol on coronary heart disease in Indian men. Atherosclerosis 2010; 210:531-5. [PMID: 20226461 DOI: 10.1016/j.atherosclerosis.2010.02.033] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/02/2010] [Revised: 02/20/2010] [Accepted: 02/23/2010] [Indexed: 10/19/2022]
Abstract
BACKGROUND Moderate alcohol consumption is known to be protective against coronary heart disease (CHD). However, the INTERHEART study, a case-control study of acute myocardial infarction (MI) patients, revealed that alcohol consumption in South Asians was not protective against CHD. We therefore planned to study cardiovascular risk factor and CHD prevalence among male alcohol users as compared to age matched lifetime abstainers. METHODS The subjects for this study were recruited from a cross-sectional survey carried out among employees and their family members aged 20-69 years in 10 medium-to-large industries from diverse sites in India, using a stratified random sampling technique. Information on education, behavioral, clinical and biochemical risk factors of CHD and alcohol use was obtained through standardized instruments. CHD diagnosis was based on Rose Questionnaire or a prior physician diagnosed CHD. RESULTS A total of 4465 subjects were present or past alcohol users. The mean age of alcohol users and lifetime abstainers was 42.8+/-11.0 years and 42.8+/-11.1 years, respectively (p=0.90). Systolic blood pressure and diastolic blood pressure were significantly higher in alcohol users (128.7+/-17.6 mmHg/80.1+/-11.3 mmHg) as compared to lifetime abstainers (126.9+/-15.9 mmHg/79.5+/-10.3 mmHg, p<0.01). Fasting blood sugar in alcohol users (98.7+/-30.5 mg%) was also significantly higher than lifetime abstainers (96.6+/-26.0 mg%, p<0.01). Total cholesterol was lower in alcohol users (179.1+/-41.1 mg%) as compared to lifetime abstainers (182.7+/-38.2 mg%, p<0.01). HDL cholesterol was higher in alcohol users (42.9+/-10.8 mg%) as compared to lifetime abstainers (41.3+/-10.0 mg%, p<0.01). Body mass index (BMI) was lower in alcohol users as compared to lifetime abstainers (22.7+/-4.1 kg/m2 vs. 24.0+/-3.3 kg/m2, p<0.001). Tobacco use was significantly higher in alcohol users (63.1% vs. 20.7%). The odds ratio (OR) of having CHD after adjusting for tobacco use, BMI and education was 1.4 (95%CI 1.0-1.9) in alcohol users as compared to controls. The OR was 1.2 (95%CI 0.8-1.6) in occasional alcohol users, 1.6 (95%CI 1.0-2.2) in regular alcohol users and 2.1 (95% CI 1.1-3.0) in past alcohol users as compared to controls. CONCLUSION We did not observe an inverse (protective) association between alcohol intake and the prevalence of CHD. In contrast, our study indicated an association in the reverse direction, suggesting possible harm of alcohol for coronary risk in Indian men. This relationship needs to be further examined in large, prospective study.
Collapse
Affiliation(s)
- A Roy
- All India Institute of Medical Sciences, New Delhi, India
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
289
|
Powles J, Hage B, Cosgrove M. Health-related expenditure patterns in selected migrant groups: data from the Australian Household Expenditure Survey, 1984. COMMUNITY HEALTH STUDIES 2010; 14:1-7. [PMID: 2331858 DOI: 10.1111/j.1753-6405.1990.tb00014.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Australians born in Italy, Greece and East and South East Asia all have substantially lower mortality levels than those born in Australia, the British Isles or Holland and Germany. Using data from the 1984 Household Expenditure Survey, the health-related consumption expenditure of these six groups was compared (excluding expenditure on medical care). The heterogeneity of household types was largely removed by confining attention to married couple households with dependent children. The two groups with mortality levels comparable to those of the Australian-born (British Isles and Holland/Germany) also shared a similar pattern of consumption expenditures. There was a tendency (not always fully consistent), for the low mortality groups to spend more on fruits, vegetables, cereal products and fish and substantially less on alcohol. Patterns that might be 'unexpected' in low mortality groups are the (presumptively) substantial expenditures on tobacco among males (especially in the Greek group) and the substantial expenditures on red meat in all three groups. Analysis of available data sets such as this can provide useful descriptions of the distribution of health-influencing behaviour in our population.
Collapse
Affiliation(s)
- J Powles
- Department of Social and Preventive Medicine, Monash Medical School, Prahran
| | | | | |
Collapse
|
290
|
Samokhvalov AV, Irving H, Mohapatra S, Rehm J. Alcohol consumption, unprovoked seizures, and epilepsy: a systematic review and meta-analysis. Epilepsia 2010; 51:1177-84. [PMID: 20074233 DOI: 10.1111/j.1528-1167.2009.02426.x] [Citation(s) in RCA: 106] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
PURPOSE The purpose of this research was to analyze and quantify the association between alcohol consumption and epilepsy as an independent disease, in part operationalized by the occurrence of unprovoked seizures, as well as to examine causality. METHODS Systematic review, meta-analysis. RESULTS A strong and consistent association between alcohol consumption and epilepsy/unprovoked seizures was found with an overall relative risk (RR) of 2.19 [95% confidence interval (CI) 1.83-2.63]. There was a dose-response relationship between the amount of alcohol consumed daily and the probability of the onset of epilepsy. Individuals consuming an average of four, six, and eight drinks daily had RRs of 1.81 (95% CI 1.59-2.07), 2.44 (95% CI 2.00-2.97), and 3.27 (95% CI 2.52-4.26), respectively, compared to nondrinkers. Several pathogenic mechanisms for the development of epilepsy in alcohol users were identified. Most of the relevant studies found that a high percentage of alcohol users with epilepsy would qualify for the criteria of alcohol dependence. Data were inconclusive regarding a threshold for the effect of alcohol, but most studies suggest that the effect may only hold for heavy drinking (four and more drinks daily). DISCUSSION The relationship between alcohol consumption and epilepsy and unprovoked seizures was quantified and several pathogenic mechanisms were suggested, although none of them has been proven to be the unique causative pathway for epilepsy. Certain limitations underlying this study require further research to clarify the outstanding statistical issues and pathogenesis of epilepsy in heavy drinkers.
Collapse
Affiliation(s)
- Andriy V Samokhvalov
- Public Health and Regulatory Policy, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
| | | | | | | |
Collapse
|
291
|
Lucas N, Windsor TD, Caldwell TM, Rodgers B. Psychological distress in non-drinkers: associations with previous heavy drinking and current social relationships. Alcohol Alcohol 2009; 45:95-102. [PMID: 19917637 DOI: 10.1093/alcalc/agp080] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
AIMS The aim of this paper is to investigate two possible explanations for the higher levels of psychological distress observed among alcohol abstainers relative to light and moderate drinkers, and to investigate possible moderating effects of age on this association. The possible explanations were that: (i) the higher level of psychological distress among abstainers is due to the presence of a subset of former heavy drinkers in this group; and (ii) abstainers have poorer social relationships than light/moderate drinkers. METHODS A national cross-sectional survey yielded data from 2856 Australians aged 20-22, 30-32 and 40-42 years (response rate 15.9%). RESULTS The sample was representative for many socio-demographic factors but under-represented people not in the labour force and over-represented those with university qualifications. In the oldest but not the younger age groups, abstainers reported significantly higher psychological distress relative to light/moderate drinkers. While abstainers in the oldest age group who were former heavy drinkers showed the highest levels of distress, excluding them from the analysis did not account for differences in distress between current abstainers and light/moderate drinkers. Abstainers aged 40-42 years were less socially integrated, less extraverted and had lower social support than light/moderate drinkers, and controlling for these factors partially explained their increased distress. CONCLUSIONS Significantly increased psychological distress of abstainers compared to light/moderate drinkers was demonstrated only in the oldest age group (40-42 years). The higher distress reported by abstainers in this age group was partially explained by abstainers having poorer social relationships than light/moderate drinkers.
Collapse
Affiliation(s)
- Nina Lucas
- National Centre for Epidemiology and Population Health, The Australian National University, Canberra, ACT, Australia.
| | | | | | | |
Collapse
|
292
|
Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, Rehm J. Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care 2009; 32:2123-32. [PMID: 19875607 PMCID: PMC2768203 DOI: 10.2337/dc09-0227] [Citation(s) in RCA: 474] [Impact Index Per Article: 29.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
OBJECTIVE To clarify the dose-response relationship between alcohol consumption and type 2 diabetes. RESEARCH DESIGN AND METHODS A systematic computer-assisted and hand search was conducted to identify relevant articles with longitudinal design and quantitative measurement of alcohol consumption. Adjustment was made for the sick-quitter effect. We used fractional polynomials in a meta-regression to determine the dose-response relationships by sex and end point using lifetime abstainers as the reference group. RESULTS The search revealed 20 cohort studies that met our inclusion criteria. A U-shaped relationship was found for both sexes. Compared with lifetime abstainers, the relative risk (RR) for type 2 diabetes among men was most protective when consuming 22 g/day alcohol (RR 0.87 [95% CI 0.76-1.00]) and became deleterious at just over 60 g/day alcohol (1.01 [0.71-1.44]). Among women, consumption of 24 g/day alcohol was most protective (0.60 [0.52-0.69]) and became deleterious at about 50 g/day alcohol (1.02 [0.83-1.26]). CONCLUSIONS Our analysis confirms previous research findings that moderate alcohol consumption is protective for type 2 diabetes in men and women.
Collapse
Affiliation(s)
- Dolly O Baliunas
- Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
| | | | | | | | | | | | | |
Collapse
|
293
|
Chikritzhs T, Fillmore K, Stockwell T. A healthy dose of scepticism: four good reasons to think again about protective effects of alcohol on coronary heart disease. Drug Alcohol Rev 2009; 28:441-4. [PMID: 19594799 DOI: 10.1111/j.1465-3362.2009.00052.x] [Citation(s) in RCA: 61] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
ISSUES Alcohol has been implicated in both the popular press and scientific literature as having a protective effect for at least a dozen conditions including coronary heart disease (CHD). APPROACH Epidemiological evidence for an apparent protective effect of alcohol on CHD is now being challenged on a number of fronts. This paper is a synopsis of those various challenges as they currently stand. KEY FINDINGS The argument that systematic misclassification of ex-drinkers and occasional drinkers to 'abstainer' categories among epidemiological studies might explain apparent protective effects of moderate alcohol consumption on CHD has recently been supported by new meta-analyses and independent research. The influence of uncontrolled or unknown factors on the relationship between alcohol and disease cannot be ruled out. Exclusion of participants on the basis of ill-health severely reduces study sample size and new analyses suggest that doing so might artificially create the appearance of protective effects. The ability of respondents to accurately recall their own alcohol consumption is in serious doubt and very few individuals maintain one single drinking level or style throughout life. The relationship between alcohol and some conditions might be a function of drinking patterns but few studies have addressed the issue. IMPLICATIONS Popular perceptions regarding the strength of evidence for alcohol's protective effect on a growing number of conditions might be misguided. CONCLUSION It is time for the wider research, health and medical community to seriously reflect on the quality of current evidence for apparent protective effects of alcohol on human disease.
Collapse
Affiliation(s)
- Tanya Chikritzhs
- National Drug Research Institute, Curtin University of Technology, Perth, Australia.
| | | | | |
Collapse
|
294
|
Ferro-Luzzi A, Cialfa E, Leclercq C, Toti E. The Mediterranean diet revisited. Focus on fruit and vegetables. Int J Food Sci Nutr 2009. [DOI: 10.3109/09637489409166170] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
295
|
Chen LY, Hardy CL. Alcohol consumption and health status in older adults: a longitudinal analysis. J Aging Health 2009; 21:824-47. [PMID: 19581424 DOI: 10.1177/0898264309340688] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Objective. This longitudinal study examines the relationship of alcohol consumption to mortality and changes in mental and functional health in older adults. Method.In a national population health survey, 4,187 participants aged 50 and older at baseline provided information on alcohol consumption, potential confounders, and follow-up vital status. Logistic regression estimated the odds ratio for mortality, increase in psychological distress, and decline in functional health 10 years later. Results. Compared with lifelong abstainers, light and moderate drinkers were at nonsignificantly lower risk of mortality. Among survivors, alcohol consumption showed no consistent relationship with increases in psychological distress. Occasional and light drinkers had significantly reduced risk of a substantial functional health decline, whereas moderate drinkers had nonsignificantly reduced risk. Discussion. Findings suggest that light-to-moderate alcohol consumption reduces the risk of substantial functional health decline in older middle-aged drinkers.
Collapse
|
296
|
Lee SJ, Sudore RL, Williams BA, Lindquist K, Chen HL, Covinsky KE. Functional limitations, socioeconomic status, and all-cause mortality in moderate alcohol drinkers. J Am Geriatr Soc 2009; 57:955-62. [PMID: 19473456 PMCID: PMC2847409 DOI: 10.1111/j.1532-5415.2009.02184.x] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVES To determine whether the survival benefit associated with moderate alcohol use remains after accounting for nontraditional risk factors such as socioeconomic status (SES) and functional limitations. DESIGN Prospective cohort. SETTING The Health and Retirement Study (HRS), a nationally representative study of U.S. adults aged 55 and older. PARTICIPANTS Twelve thousand five hundred nineteen participants were enrolled in the 2002 wave of the HRS. MEASUREMENTS Participants were asked about their alcohol use, functional limitations (activities of daily living, instrumental activities of daily living, and mobility), SES (education, income, and wealth), psychosocial factors (depressive symptoms, social support, and the importance of religion), age, sex, race and ethnicity, smoking, obesity, and comorbidities. Death by December 31, 2006, was the outcome measure. RESULTS Moderate drinkers (1 drink/d) had a markedly more-favorable risk factor profile, with higher SES and fewer functional limitations. After adjusting for demographic factors, moderate drinking (vs no drinking) was strongly associated with less mortality (odds ratio (OR)=0.50, 95% confidence interval (CI)=0.40-0.62). When traditional risk factors (smoking, obesity, and comorbidities) were also adjusted for, the protective effect was slightly attenuated (OR=0.57, 95% CI=0.46-0.72). When all risk factors including functional status and SES were adjusted for, the protective effect was markedly attenuated but still statistically significant (OR=0.72, 95% CI=0.57-0.91). CONCLUSION Moderate drinkers have better risk factor profiles than nondrinkers, including higher SES and fewer functional limitations. Although these factors explain much of the survival advantage associated with moderate alcohol use, moderate drinkers maintain their survival advantage even after adjustment for these factors.
Collapse
Affiliation(s)
- Sei J. Lee
- San Francisco VA Medical Center
- University of California, San Francisco Division of Geriatrics
| | - Rebecca L. Sudore
- San Francisco VA Medical Center
- University of California, San Francisco Division of Geriatrics
| | - Brie A. Williams
- San Francisco VA Medical Center
- University of California, San Francisco Division of Geriatrics
| | - Karla Lindquist
- University of California, San Francisco Division of Geriatrics
| | - Helen L. Chen
- San Francisco VA Medical Center
- University of California, San Francisco Division of Geriatrics
| | - Kenneth E. Covinsky
- San Francisco VA Medical Center
- University of California, San Francisco Division of Geriatrics
| |
Collapse
|
297
|
Beaglehole R, Jackson R. Alcohol, cardiovascular diseases and all causes of death: a review of the epidemiological evidence. Drug Alcohol Rev 2009; 11:275-89. [PMID: 16840082 DOI: 10.1080/09595239200185811] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
This paper reviews the epidemiological evidence on the association of alcohol consumption with the major cardiovascular diseases (hypertension, stroke and coronary heart disease), and all causes of death. The focus is on light and moderate consumption and several important methodological issues are apparent with the epidemiological evidence on alcohol and mortality. The epidemiological data justify the following recommendations on alcohol consumption. The evidence does not support the unqualified claim that light and moderate drinking confers overall health benefits. However, in persons over 35 years of age, there is no consistent evidence that daily consumption of up to 2-3 drinks in men or up to 1-2 drinks in women increases the risk of dying. Non-drinkers should not be encouraged to change their drinking status. The consumption of more than 2-3 drinks per day in men and more than 1-2 drinks per day in women should be actively discouraged. Further research on the effects of light and moderate alcohol consumption on cardiovascular disease and all causes of death are required, particularly in young people, women and the elderly.
Collapse
Affiliation(s)
- R Beaglehole
- Department of Community Health, University of Auckland, Auckland, New Zealand
| | | |
Collapse
|
298
|
Jiao L, Silverman DT, Schairer C, Thiébaut ACM, Hollenbeck AR, Leitzmann MF, Schatzkin A, Stolzenberg-Solomon RZ. Alcohol use and risk of pancreatic cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol 2009; 169:1043-51. [PMID: 19299403 DOI: 10.1093/aje/kwp034] [Citation(s) in RCA: 65] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
The epidemiologic evidence for the role of alcohol use in pancreatic cancer development is equivocal. The authors prospectively examined the relation between alcohol use and risk of pancreatic cancer among 470,681 participants who were aged 50-71 years in 1995-1996 in the US National Institutes of Health-AARP Diet and Health Study. The authors identified 1,149 eligible exocrine pancreatic cancer cases through December 2003. Multivariate Cox proportional hazards regression models were used to calculate relative risks and 95% confidence intervals with the referent group being light drinkers (<1 drink/day). The relative risks of developing pancreatic cancer were 1.45 (95% confidence interval (CI): 1.17, 1.80; P(trend) = 0.002) for heavy total alcohol use (>or=3 drinks/day, approximately 40 g of alcohol/day) and 1.62 (95% CI: 1.24, 2.10; P(trend) = 0.001) for heavy liquor use, compared with the respective referent group. The increased risk with heavy total alcohol use was seen in never smokers (relative risk = 1.35, 95% CI: 0.79, 2.30) and participants who quit smoking 10 or more years ago before baseline (relative risk = 1.41, 95% CI: 1.01, 2.00). These findings suggest a moderately increased pancreatic cancer risk with heavy alcohol use, particularly liquor; however, residual confounding by cigarette smoking cannot be completely excluded.
Collapse
Affiliation(s)
- Li Jiao
- Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA.
| | | | | | | | | | | | | | | |
Collapse
|
299
|
Middleton Fillmore K, Chikritzhs T, Stockwell T, Bostrom A, Pascal R. Alcohol use and prostate cancer: a meta-analysis. Mol Nutr Food Res 2009; 53:240-55. [PMID: 19156715 DOI: 10.1002/mnfr.200800122] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Past reviews have concluded that there is no association between alcohol use and prostate cancer incidence. We performed a meta-analysis of existing epidemiological studies finding, in contrast, evidence to suggest that prostate incidence is positively linearly associated with heavier alcohol use. This finding was largely due to the contribution of population case-control studies and those measuring men recruited before age 60. No relationship between alcohol consumption and prostate cancer was found for cohort and hospital case-control studies. Analyses of design effects modestly suggests that population case-control studies were probably better suited to identify potential alcohol-prostate cancer relationships due to the close temporal proximity of the measurement of level of alcohol consumption to diagnosis. Future efforts should be made to exclude all ill subjects from control groups/baseline samples in addition to accounting for changes in consumption with advancing age and the onset of illness. The alcohol-prostate cancer association remained significant despite controlling for the degree to which studies endeavored to eliminate false negatives from their control groups.
Collapse
|
300
|
Abstract
In this paper, the negative and the positive effects of alcohol on health are reviewed. It is first of all established facts that a high alcohol intake implies an increased risk of a large number of health outcomes, such as dementia, breast cancer, colorectal cancer, cirrhosis, upper digestive tract cancer and alcohol dependency. Second, it is justified that alcohol has beneficial effects for some individuals, especially with regard to prevention of thrombosis of the heart. The public health relevance of these results is considered. The sensible drinking limits, used in both the UK and Denmark, of a maximum of 21 drinks per week for men and 14 drinks per week for women seem valid. A broader public health message of the beneficial effects of alcohol does not seem to be of interest in Western societies, where only a very small fraction of the population are non drinkers and may have very good reasons therefore.
Collapse
Affiliation(s)
- M Grønbaek
- Centre for Alcohol Research, National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
| |
Collapse
|